Technical Analysis for DDDD - 4D Pharma Plc

Grade Last Price % Change Price Change
F 57.9232 -1.99% -1.18
DDDD closed up 1.55 percent on Wednesday, December 1, 2021, on 76 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical DDDD trend table...

Date Alert Name Type % Chg
Stochastic Buy Signal Bullish 0.00%
Multiple of Ten Bearish Other 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Multiple of Ten Bearish Other 1.55%
Wide Bands Range Expansion 1.55%
Oversold Stochastic Weakness 1.55%
Bullish Engulfing Bullish -2.48%
Multiple of Ten Bullish Other -2.48%
Older End-of-Day Signals for DDDD ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Fell Below Previous Day's Low 41 minutes ago
Down 3% 41 minutes ago
Down 2% 41 minutes ago
Down 1% 41 minutes ago
Up 3% 41 minutes ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

4D Pharma Plc Description

4D pharma plc (4D), formerly Schosween 18 Limited, is a United Kingdom-based pharmaceutical company focusing on developing various projects targeting new therapeutic areas. The principal activity of the Company is research and development of pharmaceutical products in new live biotherapeutic areas. The Company has developed its research to build MicroRx, which is a discovery methodology that is able to rationally select those bacteria that have a precise and evolved therapeutic effect. Its MicroRx methodology offers a pipeline of approximately 10 therapeutic programs covering autoimmune diseases, central nervous system (CNS) disorders and cancer. The Company uses MicroRx to develop its programs into the clinic and has approximately two programs in patient trials. The Company focuses on immune conditions, such as pediatric Crohn's, pediatric colitis and irritable bowel syndrome.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Medicine Pipe Clinic Disease Cancer Medical Specialties Diseases Targeting Clinical Medicine Rtt Autoimmune Diseases Disorders Pharmaceutical Products Bacteria Evolve Abdominal Pain Crohn's Disease Therapeutic Effect

Is DDDD a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 154.0
52 Week Low 56.0
Average Volume 1,753,299
200-Day Moving Average 92.30
50-Day Moving Average 66.43
20-Day Moving Average 70.92
10-Day Moving Average 63.68
Average True Range 5.36
ADX 24.23
+DI 15.27
-DI 26.63
Chandelier Exit (Long, 3 ATRs) 77.23
Chandelier Exit (Short, 3 ATRs) 72.64
Upper Bollinger Bands 88.37
Lower Bollinger Band 53.46
Percent B (%b) 0.16
BandWidth 49.24
MACD Line -2.75
MACD Signal Line -0.80
MACD Histogram -1.942
Fundamentals Value
Market Cap 77.65 Million
Num Shares 131 Million
EPS -38.20
Price-to-Earnings (P/E) Ratio -1.55
Price-to-Sales 162.13
Price-to-Book 4.03
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 65.25
Resistance 3 (R3) 65.27 63.23 64.23
Resistance 2 (R2) 63.23 61.67 63.23 63.88
Resistance 1 (R1) 61.17 60.70 62.20 61.15 63.54
Pivot Point 59.13 59.13 59.65 59.13 59.13
Support 1 (S1) 57.07 57.57 58.10 57.05 54.66
Support 2 (S2) 55.03 56.60 55.03 54.32
Support 3 (S3) 52.97 55.03 53.98
Support 4 (S4) 52.95